Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
about
Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Comparison of graft-versus-hos ...... le outcomes in some subgroups.
@ast
Comparison of graft-versus-hos ...... le outcomes in some subgroups.
@en
type
label
Comparison of graft-versus-hos ...... le outcomes in some subgroups.
@ast
Comparison of graft-versus-hos ...... le outcomes in some subgroups.
@en
prefLabel
Comparison of graft-versus-hos ...... le outcomes in some subgroups.
@ast
Comparison of graft-versus-hos ...... le outcomes in some subgroups.
@en
P2093
P2860
P1433
P1476
Comparison of graft-versus-hos ...... ble outcomes in some subgroups
@en
P2093
Fumihiko Kimura
Hideki Nakasone
Ichiro Kawano
JSHCT GVHD Working Group
Junichi Sugita
Kazuhiro Ikegame
Kosuke Yoshioka
Masami Inoue
Naoyuki Uchida
P2860
P304
P356
10.3324/HAEMATOL.2016.149427
P50
P577
2016-08-04T00:00:00Z